{
  "id": 2373,
  "text": "Med Oncol 33, 110 (2016).95.Buda, A., et al.Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the SNAP01 (Studio NeoAdjuvante Portio) Italian Collaborative Study.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Med Oncol 33, 110 (2016).95.Buda, A., et al.Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the SNAP01 (Studio NeoAdjuvante Portio) Italian Collaborative Study.\n\n<question>: ",
  "ChatGPT_response_0": "是的，关于宫颈癌新辅助化疗方案进行过随机试验。其中一项研究比较了紫杉醇、异环磷酰胺和顺铂联合化疗与异环磷酰胺和顺铂联合化疗后进行根治手术的疗效，这是意大利合作研究中的SNAP01（Studio NeoAdjuvante Portio）试验。",
  "query": "有没有进行过关于宫颈癌新辅助化疗方案的随机试验？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 有没有进行过关于宫颈癌新辅助化疗方案的随机试验？\n\n<reference text>: Med Oncol 33, 110 (2016).95.Buda, A., et al.Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the SNAP01 (Studio NeoAdjuvante Portio) Italian Collaborative Study.\n\n<reply>: ",
  "response": "是的，关于宫颈癌新辅助化疗方案进行过随机试验。其中一项研究比较了紫杉醇、异环磷酰胺和顺铂联合化疗与异环磷酰胺和顺铂联合化疗后进行根治手术的疗效，这是意大利合作研究中的SNAP01（Studio NeoAdjuvante Portio）试验。"
}